View full meeting coverage »

Eyetube Meeting Coverage:

2017 Retina World Congress Meeting



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Anti-VEGF Therapy and Vitrectomy in Severe PDR

J. Fernando Arevalo, MD, summarizes his discussion on time from intravitreal bevacizumab (Avastin, Genentech) injection to vitrectomy in cases of severe proliferative diabetic retinopathy (PDR). He provides important data from his group’s collaboration with other groups.

6 / 12 Series: 2017 Retina World Congress Meeting